Coreg and Tyvaso drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coreg (carvedilol) and Tyvaso (treprostinil sodium). Common drug interactions include oxygen saturation decreased among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Coreg and Tyvaso. It is created by eHealthMe based on reports of 75 people who take the same drugs from the FDA, and is updated regularly.

What is Coreg?

Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,583 Coreg users. Check the latest studies of Coreg.

What is Tyvaso?

Tyvaso has active ingredients of treprostinil sodium. eHealthMe is studying from 37,941 Tyvaso users. Check the latest studies of Tyvaso.

On Jul, 12, 2026

75 people who take Coreg and Tyvaso together, and have interactions are studied.

What are the common drug interactions of Coreg and Tyvaso, by gender? *:

female:

Oxygen saturation decreased
Dizziness
Haemoglobin decreased
Nausea (feeling of having an urge to vomit)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiac arrest
Death
Heart rate irregular
Pulmonary oedema (fluid accumulation in the lungs)
Sinusitis (inflammation of sinus)

male:

Dyspnoea (difficult or laboured respiration)
Cough
Cardiac failure
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Chronic respiratory failure
Confusional state
Hypercapnia (too much smoke)
Hypoxia (low oxygen in tissues)
Nausea (feeling of having an urge to vomit)
Oxygen saturation decreased

What are the common drug interactions of Coreg and Tyvaso, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Sinusitis (inflammation of sinus)

40-49:

Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Cough
Pain in extremity
Sepsis (a severe blood infection that can lead to organ failure and death)
Cellulitis (infection under the skin)
Contusion (a type of hematoma of tissue in which capillaries)
Decreased appetite
Exercise tolerance decreased
Fatigue (feeling of tiredness)

50-59:

Blood urine present
Decreased appetite
Diarrhoea
Dysgeusia (disorder of the sense of taste)
Dyspepsia (indigestion)
Fatigue (feeling of tiredness)
Glossodynia (a burning or painful sensation in the tongue)
Haematocrit decreased
Insomnia (sleeplessness)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

60+:

Headache (pain in head)
Dyspnoea (difficult or laboured respiration)
Dysphonia (speech disorder attributable to a disorder of phonation)
Eye pain
Insomnia (sleeplessness)
Jugular vein distension (overloaded jugular vein)
Nasal discomfort
Oropharyngeal discomfort (pain or irritation of oropharynx)
Oropharyngeal pain
Respiratory disorder (respiratory disease)

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 55 people, 73.33%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 15 people, 20.00%
Pain: 4 people, 5.33%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg and Tyvaso?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously